Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€0.17

€0.17

2.050%
0.0035
2.050%
-

-

 
30.04.24 / Tradegate WKN: A2DMQP / Name: Matinas BioPharma Holdings Inc / Stock / Biotechnology & Medical Research / Small Cap /

Matinas BioPharma Holdings Inc Stock

Matinas BioPharma Holdings Inc gained 2.050% today.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Matinas BioPharma Holdings Inc stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of Matinas BioPharma Holdings Inc in the next few years

Pros
?
M***** P*******
?
B****
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Matinas BioPharma Holdings Inc vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Matinas BioPharma Holdings Inc 2.050% 2.361% -31.732% -67.283% -15.825% -76.247% -
Chromadex Corp 1.810% 16.667% -0.617% 170.588% 140.299% -55.278% -
Organovo Holdings Inc. -9.820% 5.608% 3.958% -43.870% -2.729% -86.042% -94.330%
Intellia Therapeutics Inc 6.530% 1.365% -21.373% -41.477% -30.743% -68.574% 47.589%